Endo International (LTS:0Y5F) Beginning Cash Position : $1,076 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Endo International Beginning Cash Position?

Endo International's Beginning Cash Position for the quarter that ended in Dec. 2023 was $1,076 Mil.

Endo International's quarterly Beginning Cash Position declined from Jun. 2023 ($1,146 Mil) to Sep. 2023 ($1,111 Mil) and declined from Sep. 2023 ($1,111 Mil) to Dec. 2023 ($1,076 Mil).

Endo International's annual Beginning Cash Position increased from Dec. 2021 ($1,385 Mil) to Dec. 2022 ($1,631 Mil) but then declined from Dec. 2022 ($1,631 Mil) to Dec. 2023 ($1,249 Mil).

Endo International Beginning Cash Position Historical Data

The historical data trend for Endo International's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo International Beginning Cash Position Chart

Endo International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

1,476.84

1,720.39

1,385.00

1,631.31

1,249.24

Endo International Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															1,284.38	1,249.24	1,145.65	1,110.63	1,076.24

Endo International Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Endo International Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Endo International's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Endo International (LTS:0Y5F) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo International PLC (LTS:0Y5F) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Simmonscourt Road, Ballsbridge, First Floor, Minerva House, Dublin, IRL, 4

Website

https://www.endo.com

Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. The company generates maximum revenue from the Branded Pharmaceuticals segment. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL.

Endo International (LTS:0Y5F) Headlines

No Headlines